09/04/2024
體外癌症藥物反應測試資助計劃
Onco-PDO™ Test Sponsorship Programme
為了令更多癌症患者能受惠於Onco-PDO™體外藥物測試，Invitrocue將繼續為符合條件的志願者提供免費或半資助測試服務，並會提供Onco-PDO™報告讓主診醫生獲得患者個體化藥物反應的參考數據。
In order to benefit more cancer patients, Invitrocue continues to provide full sponsorship or 50% sponsorship for cancer patients who meet our “Sponsorship Criteria” below for Onco-PDO™ test.
此計劃有助Invitrocue研究擴展Onco-PDO™服務標準及支援藥物研發，令社會更多癌症患者可受惠於Onco-PDO™服務及改善癌症患者抗癌生活質素，有賴您的支持及參與。
This programme will also help us to extend our research and development to standardize our Onco-PDO™ service and support cancer drug development. We hope more cancer patients could benefit from the test and their quality of life could be significantly improved accordingly. Thank you for your support and participation!
資助條件Sponsorship Criteria:
1. 免費測試
100% Sponsorship
• 適用於所有診斷患有鼻咽癌、胰腺癌、肝癌及子宮頸癌的患者。
• For patients from public and private hospitals who have diagnosed with Nasopharyngeal carcinoma, Pancreatic, Liver and Cervical cancer.
2. 半資助測試
50% Sponsorship
• 公立醫院患者被診斷患有除上述四種癌症以外的癌症類型，例如但不限於肺癌、乳腺癌、結直腸癌、胃癌、膀胱癌 、 前列腺癌 、 腦癌、 腎癌 、卵巢癌 和小童神經母細胞瘤。
For patients from public hospitals who have diagnosed with other cancer type such as but not limited to Lung, Breast, Colorectal, Gastric, Bladder, Prostate, Brain, Kidney, Ovarian cancer and Paediatric Neuroblastoma.
招募計劃於2023年07月01日開展，為期1年。詳情如下：
The recruitment will start from 01 July 2023 for a period of one year. Details are as follows:
🔍適用患者 Applicable Patients:
• 對象Subjects：I-IV期癌症患者 Any stage of cancer patients (Stage I – IV)
• 年齡Age：18-70歲 18-70 years old
• 性別Gender：男女均可 Both Male and Female
• 樣本要求Specimen requirements：活性腫瘤樣本 Viable tumor specimens
• 電郵登記Email registration：contact.hk@invitrocue.com
• WhatsApp查詢Enquiry：6281 0072 (https://bit.ly/3salPAe)
***特別須知：為免患者須承擔額外進行手術的風險，Invitrocue會將已預約於2個月內進行腫瘤活組織切除手術的患者優先納入考慮
***Important notice: To avoid patients bearing the risk of additional surgery, Invitrocue will give priority to patients who have made an appointment for tumor biopsy or surgery in two months’ time.
📌報名方法 For Registration:
有興趣人士可經WhatsApp或以上電郵進行登記，Invitrocue團隊會在收到志願者登記後聯絡登記人仕進行簡單諮詢，登記人仕須同意進行約10分鐘電話訪問。
Interested patients can register via WhatsApp or the above email. The Invitrocue team will contact you for a brief consultation after receiving your registration. You must agree to have a telephone interview for about 10 minutes.
🔍計劃流程 The Workflow:
1️⃣ 志願者登記參加資助計劃後，Invitrocue團隊會先與患者會談約10分鐘以了解患者基本診斷資料；
After registration, the Invitrocue team will first talk with the patient on the phone for about 10 minutes to understand the patient’s basic diagnostic information;
2️⃣ Invitrocue團隊約見主診醫生進一步了解患者醫療診斷詳情及向醫生解釋腫瘤樣本採集須知；
Invitrocue team will make appointment to see the attending doctor to understand more about the patient’s medical diagnosis details and explain to the doctor the instructions for tumor sample collection;
3️⃣ Invitrocue約見患者及主診醫生簽署知情同意書，並與主診醫生確認為患者揀選的8種NCCN腫瘤臨床實踐指南列明之適用癌症藥物，正式參與此計劃；
Invitrocue team will meet the patient and the attending doctor to sign the Informed Consent Form and Requisition Form for Onco-PDO™ test, and confirm with the attending doctor for the selection of 8 applicable cancer drugs for testing from the NCCN Clinical Practice Guidelines in Oncology for the patient;
4️⃣ 手術當日，Invitrocue團隊會即日收集腫瘤樣本並運送至位於香港科學園之實驗室進行處理；
On the date of surgery, Invitrocue team will collect the tumor specimens on the same day and transport them to the laboratory in Hong Kong Science and Technology Parks for tissue processing;
5️⃣ 腫瘤細胞活性如成功通過測試，將繼續進行Onco-PDO™ 體外癌症藥物反應測試；
If the tumor cell viability is successfully passed, the Onco-PDO™ test will be proceeded;
6️⃣ 2 - 3週後Invitrocue團隊會將Onco-PDO™報告結果寄送主診醫生。
Within 2 – 3 weeks’ time, Invitrocue team will send the Onco-PDO™ report to the attending doctor.
Invitrocue會將收集之個人資料保密並以匿名方式進行研究，確保緊守個人私隱條例。
Invitrocue will keep all collected personal information confidential. Any relevant research will be conducted anonymously and we ensure strict compliance with personal privacy regulations.
如有任何爭議，Invitrocue (Hong Kong) Limited將保留最終決定權。
In case of any dispute, Invitrocue (Hong Kong) Limited reserves the right of final decision.
Right drug - Right patient - Right time
Like👍our page and subscribe for latest updates.
Visit us at: www.invitrocue.com
Follow us on Linkedln: https://www.linkedin.com/company/invitrocue-hk-limited/
![[健康與保健系列講座] 探索健康根源，從基因開始日期 : 2025年3月28日 (星期五)時間 : 晚上7時至8時地點 : Clearbridge Medical Center 明確醫療中心, 香港銅鑼灣軒尼詩道555號東角中心19樓2A室...](https://img3.findhealthclinics.com/133/039/1105967311330393.jpg)
![Limited seats available on a first-come, first-served basis!座位有限，先到先得！[健康與保健系列講座] 探索健康根源，從基因開始日期 : 2025年3月28日 (星期五)時間 : ...](https://img4.findhealthclinics.com/544/622/1098142335446224.jpg)
![[癌症100問講座系列] 廿幾歲? 幾廿歲? 預防子宮頸癌要快脆!!日期 : 2024年1月20日(六)時間 : 上午11時至12時地點 : 九龍深水埗石硤尾邨美禧樓2樓201A即刻click入下面條link報名啦: https://bit...](https://img3.findhealthclinics.com/636/482/822289706364823.jpg)
![[癌症100問講座系列] 廿幾歲? 幾廿歲? 預防子宮頸癌要快脆!!日期 : 2024年1月20日(六)時間 : 上午11時至12時地點 : 九龍深水埗石硤尾邨美禧樓2樓201A即刻click入下面條link報名啦: https://bit...](https://img5.findhealthclinics.com/335/634/819041203356340.jpg)
